306 related articles for article (PubMed ID: 23663483)
1. Metformin-mediated growth inhibition involves suppression of the IGF-I receptor signalling pathway in human pancreatic cancer cells.
Karnevi E; Said K; Andersson R; Rosendahl AH
BMC Cancer; 2013 May; 13():235. PubMed ID: 23663483
[TBL] [Abstract][Full Text] [Related]
2. Metformin induces apoptosis of pancreatic cancer cells.
Wang LW; Li ZS; Zou DW; Jin ZD; Gao J; Xu GM
World J Gastroenterol; 2008 Dec; 14(47):7192-8. PubMed ID: 19084933
[TBL] [Abstract][Full Text] [Related]
3. AMP-activated protein kinase inhibits IGF-I signaling and protein synthesis in vascular smooth muscle cells via stimulation of insulin receptor substrate 1 S794 and tuberous sclerosis 2 S1345 phosphorylation.
Ning J; Clemmons DR
Mol Endocrinol; 2010 Jun; 24(6):1218-29. PubMed ID: 20363874
[TBL] [Abstract][Full Text] [Related]
4. Metformin suppresses growth and adrenocorticotrophic hormone secretion in mouse pituitary corticotroph tumor AtT20 cells.
Jin K; Ruan L; Pu J; Zhong A; Wang F; Tan S; Huang H; Mu J; Yang G
Mol Cell Endocrinol; 2018 Dec; 478():53-61. PubMed ID: 30025915
[TBL] [Abstract][Full Text] [Related]
5. Dose-Dependent AMPK-Dependent and Independent Mechanisms of Berberine and Metformin Inhibition of mTORC1, ERK, DNA Synthesis and Proliferation in Pancreatic Cancer Cells.
Ming M; Sinnett-Smith J; Wang J; Soares HP; Young SH; Eibl G; Rozengurt E
PLoS One; 2014; 9(12):e114573. PubMed ID: 25493642
[TBL] [Abstract][Full Text] [Related]
6. Metformin downregulates the insulin/IGF-I signaling pathway and inhibits different uterine serous carcinoma (USC) cells proliferation and migration in p53-dependent or -independent manners.
Sarfstein R; Friedman Y; Attias-Geva Z; Fishman A; Bruchim I; Werner H
PLoS One; 2013; 8(4):e61537. PubMed ID: 23620761
[TBL] [Abstract][Full Text] [Related]
7. FAK and IGF-IR interact to provide survival signals in human pancreatic adenocarcinoma cells.
Liu W; Bloom DA; Cance WG; Kurenova EV; Golubovskaya VM; Hochwald SN
Carcinogenesis; 2008 Jun; 29(6):1096-107. PubMed ID: 18263593
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide inhibits the proliferation and invasion of pancreatic cancer cells through degradation of insulin receptor substrate-1 protein.
Sugita H; Kaneki M; Furuhashi S; Hirota M; Takamori H; Baba H
Mol Cancer Res; 2010 Aug; 8(8):1152-63. PubMed ID: 20663861
[TBL] [Abstract][Full Text] [Related]
9. erbB3 recruitment of insulin receptor substrate 1 modulates insulin-like growth factor receptor signalling in oestrogen receptor-positive breast cancer cell lines.
Knowlden JM; Gee JM; Barrow D; Robertson JF; Ellis IO; Nicholson RI; Hutcheson IR
Breast Cancer Res; 2011 Sep; 13(5):R93. PubMed ID: 21939528
[TBL] [Abstract][Full Text] [Related]
10. Palmitate affects insulin receptor phosphorylation and intracellular insulin signal in a pancreatic alpha-cell line.
Piro S; Maniscalchi ET; Monello A; Pandini G; Mascali LG; Rabuazzo AM; Purrello F
Endocrinology; 2010 Sep; 151(9):4197-206. PubMed ID: 20573722
[TBL] [Abstract][Full Text] [Related]
11. Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth.
Kisfalvi K; Eibl G; Sinnett-Smith J; Rozengurt E
Cancer Res; 2009 Aug; 69(16):6539-45. PubMed ID: 19679549
[TBL] [Abstract][Full Text] [Related]
12. Metformin inhibition of mTORC1 activation, DNA synthesis and proliferation in pancreatic cancer cells: dependence on glucose concentration and role of AMPK.
Sinnett-Smith J; Kisfalvi K; Kui R; Rozengurt E
Biochem Biophys Res Commun; 2013 Jan; 430(1):352-7. PubMed ID: 23159620
[TBL] [Abstract][Full Text] [Related]
13. Crosstalk between insulin/insulin-like growth factor-1 receptors and G protein-coupled receptor signaling systems: a novel target for the antidiabetic drug metformin in pancreatic cancer.
Rozengurt E; Sinnett-Smith J; Kisfalvi K
Clin Cancer Res; 2010 May; 16(9):2505-11. PubMed ID: 20388847
[TBL] [Abstract][Full Text] [Related]
14. R1507, an anti-insulin-like growth factor-1 receptor (IGF-1R) antibody, and EWS/FLI-1 siRNA in Ewing's sarcoma: convergence at the IGF/IGFR/Akt axis.
Huang HJ; Angelo LS; Rodon J; Sun M; Kuenkele KP; Parsons HA; Trent JC; Kurzrock R
PLoS One; 2011; 6(10):e26060. PubMed ID: 22022506
[TBL] [Abstract][Full Text] [Related]
15. High glucose induces suppression of insulin signalling and apoptosis via upregulation of endogenous IL-1beta and suppressor of cytokine signalling-1 in mouse pancreatic beta cells.
Venieratos PD; Drossopoulou GI; Kapodistria KD; Tsilibary EC; Kitsiou PV
Cell Signal; 2010 May; 22(5):791-800. PubMed ID: 20067833
[TBL] [Abstract][Full Text] [Related]
16. IGF-1 mediates PTEN suppression and enhances cell invasion and proliferation via activation of the IGF-1/PI3K/Akt signaling pathway in pancreatic cancer cells.
Ma J; Sawai H; Matsuo Y; Ochi N; Yasuda A; Takahashi H; Wakasugi T; Funahashi H; Sato M; Takeyama H
J Surg Res; 2010 May; 160(1):90-101. PubMed ID: 19560785
[TBL] [Abstract][Full Text] [Related]
17. Metformin inhibits growth of eutopic stromal cells from adenomyotic endometrium via AMPK activation and subsequent inhibition of AKT phosphorylation: a possible role in the treatment of adenomyosis.
Xue J; Zhang H; Liu W; Liu M; Shi M; Wen Z; Li C
Reproduction; 2013 Oct; 146(4):397-406. PubMed ID: 23904524
[TBL] [Abstract][Full Text] [Related]
18. Action of metformin on the insulin-signaling pathway and on glucose transport in human granulosa cells.
Rice S; Pellatt LJ; Bryan SJ; Whitehead SA; Mason HD
J Clin Endocrinol Metab; 2011 Mar; 96(3):E427-35. PubMed ID: 21209036
[TBL] [Abstract][Full Text] [Related]
19. LY294002 and metformin cooperatively enhance the inhibition of growth and the induction of apoptosis of ovarian cancer cells.
Li C; Liu VW; Chan DW; Yao KM; Ngan HY
Int J Gynecol Cancer; 2012 Jan; 22(1):15-22. PubMed ID: 22080879
[TBL] [Abstract][Full Text] [Related]
20. Metformin effects on biochemical recurrence and metabolic signaling in the prostate.
Winters B; Plymate S; Zeliadt SB; Holt S; Zhang X; Hu E; Lin DW; Morrissey C; Wooldridge B; Gore JL; Porter MP; Wright JL
Prostate; 2015 Nov; 75(15):1694-703. PubMed ID: 26201966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
